Soft Contact LensesTruEyeTotal1NCT02347631
DAILIES TOTAL1 Versus ACUVUE TruEye - Effects on the Biology of the Ocular Surface and Lid Margin
A study testing Soft Contact Lens - Daily Disposable Alcon Dailies Total 1 and ACUVUE TruEye and Soft Contact Lens - Acuvue TruEye and Alcon DAILIES TOTAL 1. in people with Soft Contact Lenses and Myopia, run by University of Texas Southwestern Medical Center at 1 site in United States.
Trial summary
This is a prospective, single center, randomized, bilateral crossover, dispensing clinical trial to evaluate the effects of the water gradient lens, DAILIES TOTAL1, on the biology of corneal epithelium over two months of daily wear compared to wear of a control high oxygen permeable silicone hydrogel daily disposable… Read more about this study
- Who is it for?
- Ages 21 to 38 yearsHealthy volunteers can take part
- Conditions the study is for
- Soft Contact Lenses, Myopia
- What is being tested?
- Soft Contact Lens - Daily Disposable Alcon Dailies Total 1 and ACUVUE TruEye and Soft Contact Lens - Acuvue TruEye and Alcon DAILIES TOTAL 1.
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 118 participants
- Where
- 1 siteUnited States
- Study dates
- Apr 2016to Jun 2018
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 to 38 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Aged 21-38 years
- Any sex, race or national origin accepted as with our past studies. Minority representation will be proactively encouraged
- Sign written informed consent
- A habitual contact lens wearer and only wear lenses for daily wear use (no overnight wear)
- Myopia range: -1.00 to -6.00 with regular astigmatism (≤1 Diopter, both eyes)
- Be willing to wear spectacles for two 1-month washout periods
Show all 12Show fewer
- Have acceptable fit with test lenses and be willing to wear lenses for the duration of the study.
- Need correction in both eyes and be correctable to within 3 letters (high contrast Snellen VA) of their current contact lens prescription at baseline in each eye with the test lenses.
- No history of allergic eye disease either seasonal or associated with previous contact lens wear.
- A routine screening complete ocular examination (COE) with ocular findings considered to be within normal limits.
- Be willing and able to follow instructions regarding the wear of the daily disposable lenses and attend the scheduled follow-up visits.
- Must be able to arrange weekday appointments between 8:00 (morning) and 12:00 (noon).
Who cannot join
- Habitual lens wearers unable to wear lenses for a minimum of 8 hours per day.
- Use of concurrent ocular medication
- Habitual toric or bifocal contact lens wearers
- Any previous history of keratorefractive surgery or recent ocular injuries or ocular surgery within the prior 3 months
- Any preexisting ocular disease
- Monocular contact lens wear
Show all 10Show fewer
- Any systemic disease or ocular abnormality that may impact optimal contact lens wear
- Use of systemic medications including but not limited to antihistamines, corticosteroids, anticholinergics or immunomodulatory agents
- Pregnancy or lactation
- Concurrent enrollment in another clinical trial
Trial locations and contacts
1 site in 1 country.
United States1 site
Aston Ambulatory Care Center
Dallas, Texas, 75390-8866
About this study
Official title: A Comparison of the Effects of Alcon DAILIES TOTAL1 and a Control High Oxygen Permeable Silicone Hydrogel Daily Disposable Contact Lens, the ACUVUE TruEye, on the Biology of the Ocular Surface and Lid Margin.
This is a prospective, single center, randomized, bilateral crossover, dispensing clinical trial to evaluate the effects of the water gradient lens, DAILIES TOTAL1, on the biology of corneal epithelium over two months of daily wear compared to wear of a control high oxygen permeable silicone hydrogel daily disposable contact lens, the ACUVUE TruEye; and to correlate these changes with alterations in the lid wiper, tear film and cellular changes at the limbus. The total proposed duration of this study is 12 months to ensure enrollment of up to 94 established contact lens wearers, with anticipated completion of 84. Data will be collected at baseline and following 2 months of daily wear for each lens type. Based upon data from the investigators previous contact lens clinical trials, a 1 month washout period is required prior to initiating lens wear and also between lens wear periods for the two types of lenses in order to eliminate any potential residual solution or lens effects on the corneal epithelium and restore homeostasis. The study is scheduled to commence upon Institutional Review Board approval.
Read the detailed description
The following Standard of Care procedures will be performed during this study:
I.Medical history and Concomitant Medication Recorded - Subjects will be interviewed about their demographics, medical and ocular History, and their allergies and medications. The study doctor or the study personnel will use paper source documents (Case Report Form) to collect and record the following data: current prescription of both contact lenses and glasses, refraction, and keratometry.
II.Comprehensive Exam
- Snellen visual acuity testing (both eyes) This will be performed using a standard projector chart at twenty feet. All patients will be refracted to ensure that visual acuity and prescription are within the inclusion criteria.
- Anterior ocular segment inspection by slit lamp examination
- Blink rate is estimated per minute (both eyes)
- Normal eyelid and eyelash position is checked for both upper and lower lids (both eyes)
- The tear meniscus is inspected and estimated for height in millimeter and presence or absence of cells and debris including mucous threads (both eyes)
- The bulbar conjunctiva, cornea, anterior chamber, iris, and crystalline lens are inspected for any abnormalities (both eyes)
- Meibomian gland orifices are inspected for signs of inflammation or plugging; eyelid skin margin is inspected for inflammation and scaling (both eyes).
- Aqueous tear production (both eyes) Following application of 1 drop of topical tetracaine, Schirmer test strips are applied to the lower fornix at the outer one-third of the lower eyelid for 3 minutes and the length of wetting recorded in mm (≥ 3.0 mm wetting/3 minutes considered within normal limits).
- Corneal staining (both eyes) One-drop of non-preserved isotonic saline is placed upon the tip of a fluorescein test strip and applied to the lower fornix with the patient looking up; presence or absence of corneal staining with fluorescein is then noted by the screening clinician.
- Intraocular pressure measurement One drop of tetracaine is applied and the cornea is gently applanated with the tip of the Goldmann tonometer to ensure Intraocular pressure ≤ 21 mmHg (both eyes).
- Evaluation of upper and lower eyelids Both upper eyelids are gently everted and both upper and lower conjunctival surfaces inspected for any abnormalities.
- Fundus examination The pupil is dilated OU (both eyes) with 1 drop each of 2.5% neosynephrine and 0.15% mydriacyl applied 1x, X2, or x3 as needed at 10 minute intervals to achieve >5 mm dilation OU. The fundus is then inspected for the appearance of the optic nerve, macula, retinal vessels and periphery and any abnormalities noted. Any abnormalities are cause for non-inclusion.
The following Experimental Procedures will be performed:
- Informed Consent Process The research staff will review the study including the informed consent in detail and allow the subject time to make an informed decision. Following review and opportunity to ask questions, the subject will be asked to sign this consent form.
II. Tear collection (both eyes) Tear collection will be performed as the first clinical test. Three µl sample volumes tears will be collected non-invasively in vivo using microcapillary tubes from the inferior tear meniscus at the temporal canthus of both eyes. Tears will be collected with the patient seated at the slit lamp with the light on low illumination.
III. Corneal epithelial cell collection (left eye only) Corneal epithelial cells can be collected non-invasively in vivo using a custom-made ocular irrigation chamber specific for these types of studies. The corneal irrigation chamber collects corneal epithelial cells into a 15 ml test tube. The patient is seated with forehead resting against a headrest; a fixation target is placed to orient the eye to be irrigated downwards; and the irrigating tip is positioned 2 mm below the corneal apex. Irrigation involves the delivery of 9 ml of sterile saline to the central cornea for a period of 1 minute via a tubing pump.
IV. In vivo confocal microscopy (right eye) A Heidelberg confocal microscope engineered in house with remote controlled scanning capabilities will be utilized in this study. One drop of topical tetracaine will be placed in the subject's eye; the subject's head is then placed in the headrest as for regular slit lamp examination. A drop of Genteal (Alcon Laboratories) is placed upon the top of the objective lens to serve as an immersion fluid. The cornea is then applanated using the standard objective lens tip. Both confocal microscopy through focusing scans and static images of the corneal epithelial surface will be acquired in the central cornea and all four quadrants of the limbus by controlling for the patient's direction of gaze. Similar image sequences will be performed to sequentially image the upper and lower lid wiper region at the midpoint of the eyelid (corresponding to the 5 and 7 o'clock position of the limbus). For upper lid imaging, the lid will be everted prior to image acquisition. Sequential imaging will allow for subsequent montage generation of the mid-point of the upper and lower lid.
Per visit details:
Visit 1: Screening Visit - Comprehensive ocular examination (Contact Lens Clinic at UTSW) (This visit will last ~ 90 minutes)
- Informed Consent reviewed and signed
- Medical History and Concomitant Meds
- Comprehensive examination
- Back-up glasses ordered as needed
- Lens fitting and ordering based on randomization into the following lens groups: Alcon DAILIES TOTAL1 Johnson and Johnson ACUVUE TruEye
- One month washout begins
Visit 2: Baseline Visit, lens 1 dispensed (This visit will last ~ 60 minutes)
- Brief screening exam (go over medical history, medications, and slit lamp exam)
- Informed consent re-reviewed
- Baseline biological indicators (outcome measures) assessed Tear collection OU (OU = both eyes) Lid wiper staining OD (OD = Right eye) Ocular irrigation (collect epithelial cells) OS (OS = Left eye) Confocal microscopy of cornea, limbus and lid margin OD
- Lenses dispensed
Visit 3: 1 week of lens wear (+/- 3 days) (This visit will last ~ 30 minutes)
- Contact lens check up
- Lens fitting
- Slit lamp examination without corneal staining
Visit 4: 2 month of lens wear (+/- 3 days) (This visit will last ~ 60 minutes)
- Brief screening exam (go over medical hx, medications, and slit lamp exam)
- Lenses and diaries collected
- Biological indicators assessed
- Lenses collected OU ii. Tear collection OU iii. Lid wiper staining OD iv. Ocular irrigation OS v. Confocal microscopy of cornea, limbus and lid margin OD d. Patient begins next 1 month washout period
Visit 5: Baseline visit, lens 2 dispensed (This visit will last ~ 60 minutes) a. Brief screening exam (go over medical hx, medications, and slit lamp exam) b. Baseline biological indicators assessed i. Lenses collected OU ii. Tear collection OU iii. Lid wiper staining OD iv. Ocular irrigation OS v. Confocal microscopy of cornea, limbus and lid margin OD c. Lenses dispensed - begin crossover phase
Visit 6: 1 week of lens wear (+/- 3 days) (This visit will last ~ 30 minutes)
- Contact lens check up
- Lens fitting
- Slit lamp examination without corneal staining
Visit 7: 2 month of lens wear (+/- 3 days) (This visit will last ~ 60 minutes)
- Brief screening exam (go over medical hx, medications, and slit lamp exam)
- Lenses and diaries collected
- Biological indicators assessed
- Lenses collected OU ii. Tear collection OU iii. Lid wiper staining OD iv. Ocular irrigation OS v. Confocal microscopy of cornea, limbus and lid margin OD d. Study completed
- Conditions
- Soft Contact Lenses, Myopia
- Being tested
- Soft Contact Lens - Daily Disposable Alcon Dailies Total 1 and ACUVUE TruEye, Soft Contact Lens - Acuvue TruEye and Alcon DAILIES TOTAL 1.
- Medical subject headings
- Myopia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Soft Contact Lens - Daily Disposable Alcon Dailies Total 1 and ACUVUE TruEyeDevice
Soft contact lens - Daily wear disposable lens to correct myopia in subjects who are nearsighted. Comparison of Alcon Dailies Total 1 versus Acuvue TruEye when worn as daily disposables over a two month period. This is a cross-over study where both brands of lenses will be worn by each participant over the course of the trial. Participants will be randomized for the order in which the two brands of lenses will be worn. There is a washout period of one month in between each 2 month contact lens wearing period.
In this experimental arm, Alcon Dailies Total 1 lenses will be worn first.
Soft Contact Lens - Acuvue TruEye and Alcon DAILIES TOTAL 1.Device
Soft contact lens - Daily wear disposable lens to correct myopia in subjects who are nearsighted. Comparison of Alcon Dailies Total 1 versus Acuvue TruEye when worn as daily disposables over a two month period. This is a cross-over study where both brands of lenses will be worn by each participant over the course of the study. Participants will be randomized for the order in which the two brands of lenses will be worn. There is a washout period of one month in between each 2 month contact lens wearing period.
In this active comparator arm, Acuvue TruEye lenses will be worn first.
| Study group | Role | What they receive |
|---|---|---|
| Alcon DAILIES TOTAL1, and ACUVUE TruEye | Experimental | Intervention: Soft Contact Lens - Daily Disposable Name - Alcon Dailies Total 1 Material - Delefilcon A Water Content - 33% Oxygen Permeability - 140 x10-11 (cm2/sec)(mL O2/mL mmHg) Oxygen Transmissibility - 156 x10-9 (cm/sec)(mL O2/mL mmHg) Base Curve - 8.5mm Manner of Wear - Daily Disposables Wearing Time - 2 months Receives: Device: Soft Contact Lens - Daily Disposable Alcon Dailies Total 1 and ACUVUE TruEye |
| ACUVUE TruEye and Alcon Dailies Total 1 | Active comparator | Intervention: Soft Contact Lens - Daily Disposable Name - Acuvue TruEye Material - Narafilcon A Water Content - 46% Oxygen Permeability - 100 x10-11 (cm2/sec)(mL O2/mL mmHg) Oxygen Transmissibility - 118 x10-9 (cm/sec)(mL O2/mL mmHg) Base Curve - 8.5mm \& 9.0mm Manner of Wear - Daily Disposables Wearing Time - 2 months Receives: Device: Soft Contact Lens - Acuvue TruEye and Alcon DAILIES TOTAL 1. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Desquamation Rate of Wearing Alcon DAILIES, Then AcuVue TruEye Contact Lenses
Group 1: Rate of desquamation of corneal epithelial cells (cells/min) will be assessed for participants wearing Alcon DAILIES contacts lenses.
- Initial 1 mo. washout period (baseline 1).
- Participant wears the Alcon DAILIES contacts for 2 months after baseline 1.
Group 2: Rate of desquamation of corneal epithelial cells (cells/min) will be assessed for participants wearing AcuVue TRUEYE contact lenses.
- Second 1 mo. washout period (baseline 2).
- Participant wears the Acuvue TRUEYE contacts for 2 months after baseline 2.
Measured: Baseline + 3 months
Desquamation Rate of Wearing Acuvue TruEye, Then Alcon DAILIES Contact Lenses
Group 1: Rate of desquamation of corneal epithelial cells (cells/min) will be assessed for participants wearing Acuvue TRUEYE contacts lenses.
- Initial 1 mo. washout period (baseline 1).
- Participant wears the Acuvue TRUEYE contacts for 2 months after baseline 1.
Group 2: Rate of desquamation of corneal epithelial cells (cells/min) will be assessed for participants wearing Alcon DAILIES contact lenses.
- Second 1 mo. washout period (baseline 2).
- Participant wears the Alcon DAILIES contacts for 2 months after baseline 2.
Measured: Baseline + 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Jan 2015 (estimated)
- Study startApr 2016
- Primary completionJun 2018
- Study completionJun 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Soft Contact LensesStudies of the same condition, open and under way.
- More trials run by University of Texas Southwestern Medical CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 118 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Texas Southwestern Medical Center
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Danielle Robertson, University of Texas Southwestern Medical Center
- Investigators
- Danielle M Robertson, O.D., PhD, Principal investigator, UTSW Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02347631
- Sponsor's protocol ID
- STU112014-068
- Acronym
- TruEyeTotal1
- Status last verified
- Nov 2020
- First submitted
- 15 Jan 2015
- Last updated
- 10 Dec 2020
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
- Individual data sharing
- No
Publications
Zhou S, Robertson DM. Wide-Field In Vivo Confocal Microscopy of Meibomian Gland Acini and Rete Ridges in the Eyelid Margin. Invest Ophthalmol Vis Sci. 2018 Aug 1;59(10):4249-4257. doi: 10.1167/iovs.18-24497.
PubMed 30128496
Study at a glance
From the registry record, last updated by the sponsor on 10 Dec 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Comparison of the Effects of Alcon DAILIES TOTAL1 and a Control High Oxygen Permeable Silicone Hydrogel Daily Disposable Contact Lens, the ACUVUE TruEye, on the Biology of the Ocular Surface and Lid Margin.
- ClinicalTrials.gov ID
- NCT02347631
- Acronym / sponsor ID
- TruEyeTotal1 / STU112014-068
- Conditions
- Soft Contact Lenses, Myopia
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 118 participants (actual)
- Lead sponsor
- University of Texas Southwestern Medical CenterUniversity, hospital or other
- Study start
- Apr 2016
- Primary completion
- Jun 2018 (actual)
- Study completion
- Jun 2018 (actual)
- First posted
- 27 Jan 2015 (estimated)
- Results
- Posted 10 Dec 2020
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a prospective, single center, randomized, bilateral crossover, dispensing clinical trial to evaluate the effects of the water gradient lens, DAILIES TOTAL1, on the biology of corneal epithelium over two months of daily wear compared to wear of a control high oxygen permeable silicone hydrogel daily disposable contact lens, the ACUVUE TruEye; and to correlate these changes with alterations in the lid wiper, tear film and cellular changes at the limbus. The total proposed duration of this study is 12 months to ensure enrollment of up to 94 established contact lens wearers, with anticipated completion of 84. Data will be collected at baseline and following 2 months of daily wear for each lens type. Based upon data from the investigators previous contact lens clinical trials, a 1 month washout period is required prior to initiating lens wear and also between lens wear periods for the two types of lenses in order to eliminate any potential residual solution or lens effects on the corneal epithelium and restore homeostasis. The study is scheduled to commence upon Institutional Review Board approval.
Detailed description
The following Standard of Care procedures will be performed during this study:
I.Medical history and Concomitant Medication Recorded - Subjects will be interviewed about their demographics, medical and ocular History, and their allergies and medications. The study doctor or the study personnel will use paper source documents (Case Report Form) to collect and record the following data: current prescription of both contact lenses and glasses, refraction, and keratometry.
II.Comprehensive Exam
- Snellen visual acuity testing (both eyes) This will be performed using a standard projector chart at twenty feet. All patients will be refracted to ensure that visual acuity and prescription are within the inclusion criteria.
- Anterior ocular segment inspection by slit lamp examination
- Blink rate is estimated per minute (both eyes)
- Normal eyelid and eyelash position is checked for both upper and lower lids (both eyes)
- The tear meniscus is inspected and estimated for height in millimeter and presence or absence of cells and debris including mucous threads (both eyes)
- The bulbar conjunctiva, cornea, anterior chamber, iris, and crystalline lens are inspected for any abnormalities (both eyes)
- Meibomian gland orifices are inspected for signs of inflammation or plugging; eyelid skin margin is inspected for inflammation and scaling (both eyes).
- Aqueous tear production (both eyes) Following application of 1 drop of topical tetracaine, Schirmer test strips are applied to the lower fornix at the outer one-third of the lower eyelid for 3 minutes and the length of wetting recorded in mm (≥ 3.0 mm wetting/3 minutes considered within normal limits).
- Corneal staining (both eyes) One-drop of non-preserved isotonic saline is placed upon the tip of a fluorescein test strip and applied to the lower fornix with the patient looking up; presence or absence of corneal staining with fluorescein is then noted by the screening clinician.
- Intraocular pressure measurement One drop of tetracaine is applied and the cornea is gently applanated with the tip of the Goldmann tonometer to ensure Intraocular pressure ≤ 21 mmHg (both eyes).
- Evaluation of upper and lower eyelids Both upper eyelids are gently everted and both upper and lower conjunctival surfaces inspected for any abnormalities.
- Fundus examination The pupil is dilated OU (both eyes) with 1 drop each of 2.5% neosynephrine and 0.15% mydriacyl applied 1x, X2, or x3 as needed at 10 minute intervals to achieve >5 mm dilation OU. The fundus is then inspected for the appearance of the optic nerve, macula, retinal vessels and periphery and any abnormalities noted. Any abnormalities are cause for non-inclusion.
The following Experimental Procedures will be performed:
- Informed Consent Process The research staff will review the study including the informed consent in detail and allow the subject time to make an informed decision. Following review and opportunity to ask questions, the subject will be asked to sign this consent form.
II. Tear collection (both eyes) Tear collection will be performed as the first clinical test. Three µl sample volumes tears will be collected non-invasively in vivo using microcapillary tubes from the inferior tear meniscus at the temporal canthus of both eyes. Tears will be collected with the patient seated at the slit lamp with the light on low illumination.
III. Corneal epithelial cell collection (left eye only) Corneal epithelial cells can be collected non-invasively in vivo using a custom-made ocular irrigation chamber specific for these types of studies. The corneal irrigation chamber collects corneal epithelial cells into a 15 ml test tube. The patient is seated with forehead resting against a headrest; a fixation target is placed to orient the eye to be irrigated downwards; and the irrigating tip is positioned 2 mm below the corneal apex. Irrigation involves the delivery of 9 ml of sterile saline to the central cornea for a period of 1 minute via a tubing pump.
IV. In vivo confocal microscopy (right eye) A Heidelberg confocal microscope engineered in house with remote controlled scanning capabilities will be utilized in this study. One drop of topical tetracaine will be placed in the subject's eye; the subject's head is then placed in the headrest as for regular slit lamp examination. A drop of Genteal (Alcon Laboratories) is placed upon the top of the objective lens to serve as an immersion fluid. The cornea is then applanated using the standard objective lens tip. Both confocal microscopy through focusing scans and static images of the corneal epithelial surface will be acquired in the central cornea and all four quadrants of the limbus by controlling for the patient's direction of gaze. Similar image sequences will be performed to sequentially image the upper and lower lid wiper region at the midpoint of the eyelid (corresponding to the 5 and 7 o'clock position of the limbus). For upper lid imaging, the lid will be everted prior to image acquisition. Sequential imaging will allow for subsequent montage generation of the mid-point of the upper and lower lid.
Per visit details:
Visit 1: Screening Visit - Comprehensive ocular examination (Contact Lens Clinic at UTSW) (This visit will last ~ 90 minutes)
- Informed Consent reviewed and signed
- Medical History and Concomitant Meds
- Comprehensive examination
- Back-up glasses ordered as needed
- Lens fitting and ordering based on randomization into the following lens groups: Alcon DAILIES TOTAL1 Johnson and Johnson ACUVUE TruEye
- One month washout begins
Visit 2: Baseline Visit, lens 1 dispensed (This visit will last ~ 60 minutes)
- Brief screening exam (go over medical history, medications, and slit lamp exam)
- Informed consent re-reviewed
- Baseline biological indicators (outcome measures) assessed Tear collection OU (OU = both eyes) Lid wiper staining OD (OD = Right eye) Ocular irrigation (collect epithelial cells) OS (OS = Left eye) Confocal microscopy of cornea, limbus and lid margin OD
- Lenses dispensed
Visit 3: 1 week of lens wear (+/- 3 days) (This visit will last ~ 30 minutes)
- Contact lens check up
- Lens fitting
- Slit lamp examination without corneal staining
Visit 4: 2 month of lens wear (+/- 3 days) (This visit will last ~ 60 minutes)
- Brief screening exam (go over medical hx, medications, and slit lamp exam)
- Lenses and diaries collected
- Biological indicators assessed
- Lenses collected OU ii. Tear collection OU iii. Lid wiper staining OD iv. Ocular irrigation OS v. Confocal microscopy of cornea, limbus and lid margin OD d. Patient begins next 1 month washout period
Visit 5: Baseline visit, lens 2 dispensed (This visit will last ~ 60 minutes) a. Brief screening exam (go over medical hx, medications, and slit lamp exam) b. Baseline biological indicators assessed i. Lenses collected OU ii. Tear collection OU iii. Lid wiper staining OD iv. Ocular irrigation OS v. Confocal microscopy of cornea, limbus and lid margin OD c. Lenses dispensed - begin crossover phase
Visit 6: 1 week of lens wear (+/- 3 days) (This visit will last ~ 30 minutes)
- Contact lens check up
- Lens fitting
- Slit lamp examination without corneal staining
Visit 7: 2 month of lens wear (+/- 3 days) (This visit will last ~ 60 minutes)
- Brief screening exam (go over medical hx, medications, and slit lamp exam)
- Lenses and diaries collected
- Biological indicators assessed
- Lenses collected OU ii. Tear collection OU iii. Lid wiper staining OD iv. Ocular irrigation OS v. Confocal microscopy of cornea, limbus and lid margin OD d. Study completed
Study design
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Alcon DAILIES TOTAL1, and ACUVUE TruEye | Experimental | Device: Soft Contact Lens - Daily Disposable Alcon Dailies Total 1 and ACUVUE TruEyeIntervention: Soft Contact Lens - Daily Disposable Name - Alcon Dailies Total 1 Material - Delefilcon A Water Content - 33% Oxygen Permeability - 140 x10-11 (cm2/sec)(mL O2/mL mmHg) Oxygen Transmissibility - 156 x10-9 (cm/sec)(mL O2/mL mmHg) Base Curve - 8.5mm Manner of Wear - Daily Disposables Wearing Time - 2 months |
| ACUVUE TruEye and Alcon Dailies Total 1 | Active comparator | Device: Soft Contact Lens - Acuvue TruEye and Alcon DAILIES TOTAL 1.Intervention: Soft Contact Lens - Daily Disposable Name - Acuvue TruEye Material - Narafilcon A Water Content - 46% Oxygen Permeability - 100 x10-11 (cm2/sec)(mL O2/mL mmHg) Oxygen Transmissibility - 118 x10-9 (cm/sec)(mL O2/mL mmHg) Base Curve - 8.5mm \& 9.0mm Manner of Wear - Daily Disposables Wearing Time - 2 months |
Who may qualify
- Ages
- 21 to 38 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (12 listed)
- Aged 21-38 years
- Any sex, race or national origin accepted as with our past studies. Minority representation will be proactively encouraged
- Sign written informed consent
- A habitual contact lens wearer and only wear lenses for daily wear use (no overnight wear)
- Myopia range: -1.00 to -6.00 with regular astigmatism (≤1 Diopter, both eyes)
Key exclusion criteria (10 listed)
- Habitual lens wearers unable to wear lenses for a minimum of 8 hours per day.
- Use of concurrent ocular medication
- Habitual toric or bifocal contact lens wearers
- Any previous history of keratorefractive surgery or recent ocular injuries or ocular surgery within the prior 3 months
- Any preexisting ocular disease
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Soft Contact Lens - Daily Disposable Alcon Dailies Total 1 and ACUVUE TruEyeSoft contact lens - Daily wear disposable lens to correct myopia in subjects who are nearsighted. Comparison of Alcon Dailies Total 1 versus Acuvue TruEye when worn as daily disposables over a two month period. This is a cross-over study where both brands of lenses will be worn by each participant over the course of the trial. Participants will be randomized for the order in which the two brands of lenses will be worn. There is a washout period of one month in between each 2 month contact lens wearing period. In this experimental arm, Alcon Dailies Total 1 lenses will be worn first. | Device | Alcon DAILIES TOTAL1, and ACUVUE TruEye |
| Soft Contact Lens - Acuvue TruEye and Alcon DAILIES TOTAL 1.Soft contact lens - Daily wear disposable lens to correct myopia in subjects who are nearsighted. Comparison of Alcon Dailies Total 1 versus Acuvue TruEye when worn as daily disposables over a two month period. This is a cross-over study where both brands of lenses will be worn by each participant over the course of the study. Participants will be randomized for the order in which the two brands of lenses will be worn. There is a washout period of one month in between each 2 month contact lens wearing period. In this active comparator arm, Acuvue TruEye lenses will be worn first. | Device | ACUVUE TruEye and Alcon Dailies Total 1 |
Primary outcome
Desquamation Rate of Wearing Alcon DAILIES, Then AcuVue TruEye Contact Lenses
Time frame: Baseline + 3 months
Group 1: Rate of desquamation of corneal epithelial cells (cells/min) will be assessed for participants wearing Alcon DAILIES contacts lenses. 1. Initial 1 mo. washout period (baseline 1). 2. Participant wears the Alcon DAILIES contacts for 2 months after baseline 1. Group 2: Rate of desquamation of corneal epithelial cells (cells/min) will be assessed for participants wearing AcuVue TRUEYE contact lenses. 1. Second 1 mo. washout period (baseline 2). 2. Participant wears the Acuvue TRUEYE contacts for 2 months after baseline 2.
Desquamation Rate of Wearing Acuvue TruEye, Then Alcon DAILIES Contact Lenses
Time frame: Baseline + 3 months
Group 1: Rate of desquamation of corneal epithelial cells (cells/min) will be assessed for participants wearing Acuvue TRUEYE contacts lenses. 1. Initial 1 mo. washout period (baseline 1). 2. Participant wears the Acuvue TRUEYE contacts for 2 months after baseline 1. Group 2: Rate of desquamation of corneal epithelial cells (cells/min) will be assessed for participants wearing Alcon DAILIES contact lenses. 1. Second 1 mo. washout period (baseline 2). 2. Participant wears the Alcon DAILIES contacts for 2 months after baseline 2.
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Dec 2020.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- Derived from this study: PubMed 30128496Zhou S, Robertson DM. Wide-Field In Vivo Confocal Microscopy of Meibomian Gland Acini and Rete Ridges in the Eyelid Margin. Invest Ophthalmol Vis Sci. 2018 Aug 1;59(10):4249-4257. doi: 10.1167/iovs.18-24497.
- Individual participant dataSharing planned: No
Related trials for Soft Contact Lenses
Recruiting
Evaluation of Two Monthly Silicone Hydrogel Multifocal Toric in Soft Contact Lens Wearers
Astigmatism, Myopia
Recruiting
Myopia Control Using Novel Soft Contact Lenses
Myopia
Enrolling by invitation
Smart Soft Contact Lenses for Monitoring Glaucoma
Glaucoma
Not yet recruiting
Contact Lenses to Slow Myopia Progression in Adults
Myopia, Myopia Progression
Enrolling by invitation
Management of Myopia in University Students Using Dual Focus Soft Contact Lenses
Myopia, Progressive
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Danielle M Robertson, O.D., PhD principal investigator
UTSW Medical Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Soft Contact Lens - Daily Disposable Alcon Dailies Total 1 and ACUVUE TruEye and Soft Contact Lens - Acuvue TruEye and Alcon DAILIES TOTAL 1. in people with Soft Contact Lenses and Myopia, run by University of Texas Southwestern Medical Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 12 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 10 Dec 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 10 Dec 2020). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Desquamation Rate of Wearing Alcon DAILIES, Then AcuVue TruEye Contact Lenses (time frame: Baseline + 3 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02347631, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Dec 2020.